Sign In

Christof Neuman

IPDx: Decoding the immune system

Christof Neuman is the founder of IPDx, a company focused on developing diagnostic solutions in the healthcare sector, particularly in immunoprofiling for disease and health risk assessment. IPDx, established in 2015 and based in Leipzig, Germany, specializes in multi-biomarker point-of-care tests for various types of cancer and is also working on early-stage predictive solutions for type 2 diabetes.24

Neuman's academic background includes a degree from San Diego State University, and he has experience in the fields of immunology and diagnostics. His work at IPDx emphasizes innovation and long-term business cooperation, particularly between Estonia and Norway.5 Under his leadership, IPDx has positioned itself as a key player in the healthcare diagnostics market, leveraging advanced technologies to enhance patient care.2

In addition to his role at IPDx, Neuman has been involved in various research initiatives and has contributed to advancements in healthcare technology.13

Related Questions

What are Christof Neuman's main achievements at IPDx?
How did Christof Neuman start his career in the healthcare technology sector?
What are the key projects Christof Neuman has worked on at IPDx?
How does IPDx's approach to immunoprofiling differ from other companies?
What is the significance of the Mosaic Score for IPDx?
Christof Neuman
Christof Neuman, photo 1
Add to my network

Location

Estonia